Home Newsfeeds Watching Uxin Limited; Zacks Small Cap Research Sets 11.25 Price Valuation

Watching Uxin Limited; Zacks Small Cap Research Sets 11.25 Price Valuation

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_01052023_UXIN_Kerr.pdf

byBenzinga Newsdesk

January 5, 2023

1 minute read

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_01052023_UXIN_Kerr.pdf

Tiziana Life Sciences Announces Additional Clinical Improvements In The Second Patient With Non-Active Secondary Progressive Multiple Sclerosis After Eleven Months Of Dosing With Intranasal Foralumab

By Benzinga Newsdesk

January 3, 8:05 AM

Tiziana Life Sciences Ltd. (NASDAQ:TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today

TLSA

McDonald’s Will Pay You To Eat Its Happy Meals, Here’s How

By AJ Fabino

July 28, 12:15 PM

No, you didn’t read that headline wrong, and this isn’t some elaborate fast-food prank. You can get paid…

MCD

Mizuho Maintains Buy on Nomad Foods, Lowers Price Target to $24

By Benzinga Newsdesk

September 2, 7:41 AM

Mizuho analyst John Baumgartner maintains Nomad Foods (NYSE:NOMD) with a Buy and lowers the price target from $25 to $24.

NOMD

Danimer Scientific Invited Into Due Diligence And Term Sheet Negotiation Phase For A Federal Financing Bank Loan And DOE Loan Guarantee

By Happy Mohamed

August 8, 5:04 PM

Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today

DNMR

Watching Uxin Limited; Zacks Small Cap Research Sets 11.25 Price Valuation

Related Posts

Tiziana Life Sciences Announces Additional Clinical Improvements In The Second Patient With Non-Active Secondary Progressive Multiple Sclerosis After Eleven Months Of Dosing With Intranasal Foralumab

McDonald’s Will Pay You To Eat Its Happy Meals, Here’s How

Mizuho Maintains Buy on Nomad Foods, Lowers Price Target to $24

Danimer Scientific Invited Into Due Diligence And Term Sheet Negotiation Phase For A Federal Financing Bank Loan And DOE Loan Guarantee